TAM
XENT

Tiverton Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Tiverton Asset Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8,366
Closed -$329K – 530
2018
Q1 		$329K Sell
8,366
-25,000
-75% -$913K 0.02% 254
2017
Q4 		$1.08M Sell
33,366
-16,634
-33% -$499K 0.07% 179
2017
Q3 		$1.56M Sell
50,000
-6,300
-11% -$186K 0.09% 148
2017
Q2 		$1.57M Sell
56,300
-18,700
-25% -$423K 0.09% 159
2017
Q1 		$1.29M Hold
75,000
– – 0.07% 162
2016
Q4 		$908K Hold
75,000
– – 0.05% 172
2016
Q3 		$1.19M Buy
+75,000
New +$1.13M 0.1% 138

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Tiverton Asset Management's XENT Position: Q2 2018 in Review

Tiverton Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 8,366 shares — an estimated $329K sold.

Tiverton Asset Management first reported a position in XENT in Q3 2016 and held it in 7 quarters. The position peaked at $1.57M in Q2 2017. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • Tiverton Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 8,366 Intersect ENT, Inc shares in Q2 2018, an estimated $329K.
  • Tiverton Asset Management first reported a position in Intersect ENT, Inc in Q3 2016 and held it in 7 quarters.
  • Tiverton Asset Management's Intersect ENT, Inc position peaked at $1.57M in Q2 2017.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Tiverton Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.